Overview
Kazunori Shimizu practices practicing medicine in Nagoya, Japan.
Their clinical expertise encompasses Muscle Atrophy, Lung Metastases, and Hepatoblastoma.
They are actively involved in clinical research, co-authoring 69 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazunori Shimizu
Is Kazunori Shimizu a top-rated expert for Muscle Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Kazunori Shimizu is classified as an Experienced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazunori Shimizu participate in research or clinical trials?
Yes. Kazunori Shimizu has published 69 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Kazunori Shimizu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HepatoblastomaShimizu isExperienced. Learn about Hepatoblastoma.
- Lung MetastasesShimizu isExperienced. Learn about Lung Metastases.
- Muscle AtrophyShimizu isExperienced. Learn about Muscle Atrophy.